The Journal of Immunology, Vol 152, Issue 9 4235-4241, Copyright © 1994 by American Association of Immunologists

ARTICLES

How many specific B cells are needed to protect against a virus?

MF Bachmann, TM Kundig, CP Kalberer, H Hengartner and RM Zinkernagel
Department of Pathology, University of Zurich, Switzerland.

The size of the Ab repertoire has been estimated to comprise theoretically somewhere between > 10(10) and approximately 10(4) specificities, dependent on the criteria used. In an attempt to estimate the anti-viral protective Ab repertoire of the mouse the B cell and Ab-forming cell (AFC) frequencies and protective neutralizing Ab levels during the course of an infection with vesicular stomatitis virus (VSV) were analyzed. Determination of AFC frequencies, limiting dilution assays, and adoptive transfer experiments to SCID mice revealed that during the acute phase (day 8) of the immune response, more than 50% of all IgG2a-producing AFCs were specific for VSV, most of them recognizing the neutralizing determinant. In a later phase (days 21 or 50), 10 to 20 times fewer VSV-specific AFCs were present, corresponding to a frequency of approximately 1:10(4) spleen cells. Finally, in a protection assay in SCID mice, adoptively transferred protective Ab concentrations were found to be approximately 1 to 10 micrograms Ab/ml mouse serum. Because during the memory phase of the anti-VSV response usually 10(4) AFC/mouse are engaged to maintain a high level of memory IgG against the neutralizing determinant on VSV and if one assumes a total number of about 10(6) AFCs/mouse, these data suggest a rather limited neutralizing anti-viral protective memory-AFC repertoire of 10(2) to 10(4) different specificities.

This article has been cited by other articles:

				D. Gatto, T. Pfister, A. Jegerlehner, S. W. Martin, M. Kopf, and M. F. Bachmann Complement receptors regulate differentiation of bone marrow plasma cell precursors expressing transcription factors Blimp-1 and XBP-1 J. Exp. Med., March 21, 2005; 201(6): 993 - 1005. [Abstract] [Full Text] [PDF]

				P. J. Klasse and Q. J. Sattentau Occupancy and mechanism in antibody-mediated neutralization of animal viruses J. Gen. Virol., September 1, 2002; 83(9): 2091 - 2108. [Abstract] [Full Text] [PDF]

				D. ENSHELL-SEIJFFERS, L. SMELYANSKI, N. VARDINON, I. YUST, and J. M. GERSHONI Dissection of the humoral immune response toward an immunodominant epitope of HIV: a model for the analysis of antibody diversity in HIV+ individuals FASEB J, October 1, 2001; 15(12): 2112 - 2120. [Abstract] [Full Text] [PDF]

				U. Kalinke, A. Oxenius, C. Lopez-Macias, R. M. Zinkernagel, and H. Hengartner Virus neutralization by germ-line vs. hypermutated antibodies PNAS, August 29, 2000; 97(18): 10126 - 10131. [Abstract] [Full Text] [PDF]

				A. F. Ochsenbein, D. D. Pinschewer, B. Odermatt, M. C. Carroll, H. Hengartner, and R. M. Zinkernagel Protective T Cell-independent Antiviral Antibody Responses Are Dependent on Complement J. Exp. Med., October 18, 1999; 190(8): 1165 - 1174. [Abstract] [Full Text] [PDF]

				C. Lopez-Macias, U. Kalinke, M. Cascalho, M. Wabl, H. Hengartner, R. M. Zinkernagel, and A. Lamarre Secondary Rearrangements and Hypermutation Generate Sufficient B Cell Diversity to Mount Protective Antiviral Immunoglobulin Responses J. Exp. Med., June 7, 1999; 189(11): 1791 - 1798. [Abstract] [Full Text] [PDF]

				K. J. Maloy, C. Burkhart, G. Freer, T. Rulicke, H. Pircher, D. H. Kono, A. N. Theofilopoulos, B. Ludewig, U. Hoffmann-Rohrer, R. M. Zinkernagel, et al. Qualitative and Quantitative Requirements for CD4+ T Cell-Mediated Antiviral Protection J. Immunol., March 1, 1999; 162(5): 2867 - 2874. [Abstract] [Full Text] [PDF]

				K. J. Maloy, B. Odermatt, H. Hengartner, and R. M. Zinkernagel Interferon gamma -producing gamma delta T cell-dependent antibody isotype switching in the absence of germinal center formation during virus infection PNAS, February 3, 1998; 95(3): 1160 - 1165. [Abstract] [Full Text] [PDF]

				M. F. Bachmann, U. Kalinke, A. Althage, G. Freer, C. Burkhart, H. Roost, M. Aguet, H. Hengartner, and R. M. Zinkernagel The Role of Antibody Concentration and Avidity in Antiviral Protection Science, June 27, 1997; 276(5321): 2024 - 2027. [Abstract] [Full Text]